Startseite › Lungenkrebs › Tennessee › Memphis
Klinische Studien zu Lungenkrebs in Memphis, TN
18 Studien zu Lungenkrebs suchen Teilnehmer an Standorten in und um Memphis (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Teilnehmer gesuchtPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi entfernt
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi entfernt
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Teilnehmer gesuchtPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi entfernt
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi entfernt
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Teilnehmer gesuchtPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi entfernt
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi entfernt
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Teilnehmer gesuchtPhase 3
- Regional One Health, Memphis
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 2
- Research Site, Memphis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Baptist Cancer Center, Memphis
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Baptist Memorial Hospital-Memphis, Memphis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Baptist Cancer Center, Southaven · 11 mi entfernt
- West Cancer Center & Research Institute, Germantown · 14 mi entfernt
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi entfernt
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi entfernt
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Teilnehmer gesuchtPhase 1/2
- Baptist Medical Center, Memphis
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Teilnehmer gesuchtPhase 2
- Baptist Cancer Center, Memphis
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi entfernt
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi entfernt
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Teilnehmer gesuchtPhase 1/2
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi entfernt
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi entfernt
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2/3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi entfernt
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi entfernt
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Baptist Clinical Research Institute, Memphis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Memphis
Lungenkrebs-Studien in anderen Städten
- Houston, TX78 Studien
- Boston, MA62 Studien
- New York City, NY60 Studien
- Los Angeles, CA45 Studien
- Washington, DC41 Studien
- Arlington, VA41 Studien
- Chicago, IL41 Studien
- Nashville, TN40 Studien
- Baltimore, MD40 Studien
- St. Louis, MO39 Studien
- Columbus, OH37 Studien
- Philadelphia, PA36 Studien
Weitere Studien in Memphis
- Krebs (alle Arten)31 Studien
- Nichtkleinzelliges Lungenkarzinom23 Studien
- Brustkrebs22 Studien
- Sichelzellenanämie18 Studien
- Akute lymphoblastische Leukämie16 Studien
- Akute myeloische Leukämie15 Studien
- Herzinsuffizienz13 Studien
- Kolorektales Karzinom11 Studien
- Weichteilsarkom11 Studien
- Melanom11 Studien
- Prostatakrebs11 Studien
- Osteosarkom10 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.